Bounty mutiny descendants have low rates of myopia: study

July 20, 2012

Descendants of a British mutiny who have lived for generations in the Pacific have among the lowest rates of myopia in the world, according to an Australian study.

The study examined among the descendants of the Bounty sailors and their Polynesian wives who settled on Pitcairn Island after the mutiny in 1789 and who then moved to Norfolk Island off Australia's east coast.

"One component of the study has found the prevalence of myopia (near-sightedness) on Norfolk Island is lower than on mainland Australia," said University of Western Australia academic David Mackey.

"But there was a two-fold higher prevalence of myopia in people without Pitcairn ancestry.

"We found the rate of Pitcairn group myopia is approximately one-half that of the Australian population and as a result would be ranked among one of the lowest rates in the world."

Pitcairn was settled in 1789 by mutineers from the British naval ship the Bounty, who famously set their captain William Bligh adrift in the South Pacific.

Many of the families of the mutineers moved from Pitcairn, a five-square-kilometre island midway between New Zealand and Chile, to the larger Norfolk Island in 1856.

Mackey, who is managing director of the Lions Eye Institute which carried out the study, said Norfolk Island was unique because almost half the islanders could trace their ancestry back to the original Pitcairn population of just nine British mutineers, 12 Tahitian women and six Tahitian men.

He said nearly 800 of the island's 1,200 inhabitants took part in the study.

The researchers were unable to conclude why the levels of myopia were different but said further research may allow the identification of genes that differ between Bounty descendants and other islanders, given they had similar exposure to sunlight.

A lack of sunlight is thought to be related to , with exposure to the sun's rays believed to stimulate production of the , which in turn stops the from growing elongated and distorting the focus of light entering the eye.

Explore further: New hope for migraine sufferers: Female gene link identified

Related Stories

New hope for migraine sufferers: Female gene link identified

June 4, 2012
New hope has arrived for migraine sufferers following a Griffith University study with the people of Norfolk Island.

East Asians short-sighted for snubbing outdoors: study

May 4, 2012
Snubbing the outdoors for books, video games and TV is the reason up to nine in ten school-leavers in big East Asian cities are near-sighted, according to a study published on Friday.

Researchers identify gene that leads to myopia (nearsightedness)

September 1, 2011
A Ben-Gurion University of the Negev research group led by Prof. Ohad Birk has identified a gene whose defect specifically causes myopia or nearsightedness.

Recommended for you

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

Drug shows promise against vision-robbing disease in seniors

June 21, 2017
An experimental drug is showing promise against an untreatable eye disease that blinds older adults—and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

Reproducing a retinal disease on a chip

June 15, 2017
Approximately 80% of all sensory input is received via the eyes, so suffering from chronic retinal diseases that lead to blindness causes a significant decrease in the quality of life (QOL). And because retinal diseases are ...

New gene therapy for vision loss proven safe in humans

May 16, 2017
In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.